DNA Valley with C.J. Overly

Jeff Galvin, CEO of American Gene Technologies® (AGT™), speaks with C.J. Overly, Senior Project Manager of BXP Life Sciences, about the dramatic growth of the biotech sector in Montgomery County, Maryland. Weighing in on the ever-growing need for accessibility, Galvin and Overly emphasize the benefit that biotech settlements bring to suburban areas. Otherwise known as DNA Valley, Montgomery County is renowned for its concentration of cutting-edge life science firms and has become the epicenter of groundbreaking discoveries in the field. Aiming to further establish itself within this ecosystem, BXP bought property in Rockville dedicated to lab redevelopment in the Shady Grove life sciences cluster.

Meanwhile, AGT launched their spinoff company, Addimmune™, which is solely focused on finding a potential cure for HIV. Leveraging Addimmune as a method of connection, Galvin strives to encourage deeper connections between Montgomery County firms and leaders – with the ultimate goal of formulating cures to some of the world’s deadliest illnesses.

To learn more about BXP and Montgomery County acquisition, please visit: https://www.bxp.com/news/bxp-life-sci...

About American Gene Technologies: American Gene Technologies is a gene and cell therapy company with a proprietary gene-delivery platform for rapid development of gene therapies to cure infectious diseases, cancers, and inherited disorders. Its mission is to transform people's lives through genetic medicines that rid the body of disease.

Visit our website: https://www.americangene.com
Subscribe to our newsletter: https://bit.ly/3ughPNR

Follow AGT on social media:
Facebook:   / amerigene  
Twitter:   / americangene  
LinkedIn:   / american-gene-technologies-international-inc   Instagram:   / americangenetechnologies  
Threads: https://www.threads.net/@americangene...

Follow Jeff Galvin on social media:
Twitter: @jeffreygalvin   / jeffreygalvin  
LinkedIn:   / jeff-galvin  

About Addimmune: Addimmune was founded in 2023 to cure HIV with promising gene therapy technologies. Building upon the success of
American Gene Technologies’ HIV clinical trial, Addimmune is solely focused on developing and commercializing an effective and lasting cure for HIV.

Visit our website: https://www.addimmune.com/
Subscribe to our newsletter: https://www.addimmune.com/in-the-news/

Follow Addimmune on social media: Facebook:   / addimmune   Twitter:   / addimmune  
LinkedIn:   / addimmune  
Instagram:   / addimmune  
Threads: https://www.threads.net/@addimmune